Axiom Catalyst

Live From the Congress floor, ESMO 2022: RCC


Listen Later

Join us as we discuss the latest developments in RCC coming out of ESMO22. In this episode, we recap the impact of 3 failed checkpoint-based regimen trials within the (neo)adjuvant setting and the first positive triplet data for advanced RCC.

...more
View all episodesView all episodes
Download on the App Store

Axiom CatalystBy Axiom Healthcare Strategies